Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Candela

This article was originally published in The Gray Sheet

Executive Summary

Two-for-one stock split approved by the board will be effective March 16 for shareholders of record as of Feb. 16. The aesthetic laser maker, which recently launched the 510(k)-cleared GentleYAG laser for treating unwanted leg veins and hair removal on dark and tanned skin, and the VBeam and CBeam lasers for non-invasive acne treatment, reported Jan. 27 second fiscal quarter sales of $23.9 mil., up 33%. Earnings of $2.4 mil. for the three months ended Dec. 27 compare with $0.8 mil. for the same period last year...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019666

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel